US health authorities report rise in antibiotic-resistant Shigella

United States health authorities have raised concerns regarding the spread of antibiotic-resistant Shigella bacteria, a pathogen causing highly contagious intestinal infections. While the situation is not classified as an abnormally large epidemic, the rise of treatment-resistant strains has become a significant public health challenge as traditional medical interventions are proving increasingly ineffective.

According to the Centers for Disease Control and Prevention (CDC), there were 13,921 diagnosed cases of shigellosis reported by September 26, 2026. This figure is approaching the 14,277 cases recorded during the entirety of the previous year. Scientists are particularly concerned about infections among adult men, where sexual contact has been identified as a significant factor in the transmission of these highly resistant bacterial pathogens.

This trend follows an advisory report released by health experts and federal agencies in April 2026, which underscored the growing dangers of antimicrobial resistance. Authorities are now urging increased public awareness and enhanced screening protocols to curb transmission rates, as researchers continue to monitor the evolving pathogens to mitigate the risk of widespread, untreatable outbreaks.